Close
  Indian J Med Microbiol
 

Figure 4: Morphological changes of MDA-MB-231 cells by acridine orange/ethidium bromide staining, ×20. (a) Control cells; (b) Cells treated with doxorubicin at 0.58 μg/mL; (c) Cells treated with MGHV inhibitory concentration 50 concentration; White arrow – Normal cells; Blue arrow – Early apoptotic cells; Green arrow – Late apoptotic cells; Red arrow – Necrotic cells; Black arrows – Apoptotic body formation; Orange arrow – Nuclear condensation and marginalization; Black – Nuclear fragmentation

Figure 4: Morphological changes of MDA-MB-231 cells by acridine orange/ethidium bromide staining, ×20. (a) Control cells; (b) Cells treated with doxorubicin at 0.58 μg/mL; (c) Cells treated with MGHV inhibitory concentration 50 concentration; White arrow – Normal cells; Blue arrow – Early apoptotic cells; Green arrow – Late apoptotic cells; Red arrow – Necrotic cells; Black arrows – Apoptotic body formation; Orange arrow – Nuclear condensation and marginalization; Black – Nuclear fragmentation